Cresset Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$454K Sell
7,085
-548
-7% -$36K ﹤0.01% 1211
2026
Q1
$543K Buy
7,633
+122
+2% +$9.62K ﹤0.01% 1027
2025
Q4
$616K Buy
7,511
+297
+4% +$23.1K ﹤0.01% 981
2025
Q3
$542K Buy
7,214
+201
+3% +$15K ﹤0.01% 994
2025
Q2
$519K Buy
7,013
+76
+1% +$5.29K ﹤0.01% 914
2025
Q1
$560K Sell
6,937
-187
-3% -$16.1K ﹤0.01% 1007
2024
Q4
$557K Sell
7,124
-20,390
-74% -$1.73M ﹤0.01% 1036
2024
Q3
$2.58M Buy
27,514
+1,659
+6% +$139K 0.01% 681
2024
Q2
$2.01M Buy
25,855
+3,028
+13% +$247K 0.01% 720
2024
Q1
$2.08M Buy
22,827
+2,484
+12% +$207K 0.01% 626
2023
Q4
$1.57M Buy
20,343
+4,051
+25% +$284K 0.01% 687
2023
Q3
$1.11M Sell
16,292
-606
-4% -$44.1K ﹤0.01% 808
2023
Q2
$1.37M Buy
16,898
+11,674
+223% +$932K ﹤0.01% 792
2023
Q1
$429K Buy
+5,224
New +$373K 0.01% 530

Other funds holding GEHC

Cresset Asset Management's GEHC Position: Q2 2026 in Review

Cresset Asset Management reduced its GE HealthCare (GEHC) stake by 7.2% in Q2 2026, selling an estimated $36K and leaving 7,085 shares worth $454K. The position accounts for ﹤0.01% of the portfolio, ranked #1211.

Cresset Asset Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.58M in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Cresset Asset Management held 7,085 shares of GE HealthCare worth $454K as of Q2 2026.
  • Cresset Asset Management sold 548 GE HealthCare shares in Q2 2026, an estimated $36K.
  • GE HealthCare made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1211 holding.
  • Cresset Asset Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Cresset Asset Management's GE HealthCare position peaked at $2.58M in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.